BioCentury
ARTICLE | Distillery Therapeutics

Targeting ferroptosis directly or via CD36 inhibition for melanoma, MM, NSCLC

April 6, 2021 9:40 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; multiple myeloma (MM); non-small cell lung cancer (NSCLC)...

BCIQ Target Profiles

CD36 (GPIV)